[HTML][HTML] Potent and protective IGHV3-53/3-66 public antibodies and their shared escape mutant on the spike of SARS-CoV-2
Neutralizing antibodies (nAbs) to SARS-CoV-2 hold powerful potentials for clinical
interventions against COVID-19 disease. However, their common genetic and biologic …
interventions against COVID-19 disease. However, their common genetic and biologic …
[HTML][HTML] Potent and protective IGHV3-53/3-66 public antibodies and their shared escape mutant on the spike of SARS-CoV-2
Q Zhang, B Ju, J Ge, JFW Chan, L Cheng… - Nature …, 2021 - ncbi.nlm.nih.gov
Neutralizing antibodies (nAbs) to SARS-CoV-2 hold powerful potentials for clinical
interventions against COVID-19 disease. However, their common genetic and biologic …
interventions against COVID-19 disease. However, their common genetic and biologic …
Potent and protective IGHV3-53/3-66 public antibodies and their shared escape mutant on the spike of SARS-CoV-2
Q Zhang, B Ju, J Ge, JFW Chan, L Cheng… - Nature …, 2021 - ideas.repec.org
Neutralizing antibodies (nAbs) to SARS-CoV-2 hold powerful potentials for clinical
interventions against COVID-19 disease. However, their common genetic and biologic …
interventions against COVID-19 disease. However, their common genetic and biologic …
Potent and protective IGHV3-53/3-66 public antibodies and their shared escape mutant on the spike of SARS-CoV-2
Q Zhang, B Ju, J Ge, JFW Chan… - Nature …, 2021 - ui.adsabs.harvard.edu
Neutralizing antibodies (nAbs) to SARS-CoV-2 hold powerful potentials for clinical
interventions against COVID-19 disease. However, their common genetic and biologic …
interventions against COVID-19 disease. However, their common genetic and biologic …
Potent and protective IGHV3-53/3-66 public antibodies and their shared escape mutant on the spike of SARS-CoV-2.
Q Zhang, B Ju, J Ge, JFW Chan… - Nature …, 2021 - search.ebscohost.com
Neutralizing antibodies (nAbs) to SARS-CoV-2 hold powerful potentials for clinical
interventions against COVID-19 disease. However, their common genetic and biologic …
interventions against COVID-19 disease. However, their common genetic and biologic …
Potent and protective IGHV3-53/3-66 public antibodies and their shared escape mutant on the spike of SARS-CoV-2
Q Zhang, B Ju, J Ge, JFW Chan, L Cheng… - Nature …, 2021 - hub.hku.hk
Neutralizing antibodies (nAbs) to SARS-CoV-2 hold powerful potentials for clinical
interventions against COVID-19 disease. However, their common genetic and biologic …
interventions against COVID-19 disease. However, their common genetic and biologic …
Potent and protective IGHV3-53/3-66 public antibodies and their shared escape mutant on the spike of SARS-CoV-2.
Q Zhang, B Ju, J Ge, JF Chan, L Cheng… - Nature …, 2021 - europepmc.org
Neutralizing antibodies (nAbs) to SARS-CoV-2 hold powerful potentials for clinical
interventions against COVID-19 disease. However, their common genetic and biologic …
interventions against COVID-19 disease. However, their common genetic and biologic …
[PDF][PDF] Potent and protective IGHV3-53/3-66 public antibodies and their shared escape mutant on the spike of SARS-CoV-2
Q Zhang, B Ju, J Ge, JFW Chan, L Cheng, R Wang… - scholar.archive.org
RBD-specific monoclonal antibodies (mAbs) with 165 distinct sequences derived from single
B cell of eight SARS-CoV-2-infected individuals 19. From the initial studies of 18 antibodies …
B cell of eight SARS-CoV-2-infected individuals 19. From the initial studies of 18 antibodies …
Potent and protective IGHV3-53/3-66 public antibodies and their shared escape mutant on the spike of SARS-CoV-2
Q Zhang, B Ju, J Ge, JFW Chan, L Cheng… - Nature …, 2021 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Neutralizing antibodies (nAbs) to SARS-CoV-2
hold powerful potentials for clinical interventions against COVID-19 disease. However, their …
hold powerful potentials for clinical interventions against COVID-19 disease. However, their …
Potent and protective IGHV3-53/3-66 public antibodies and their shared escape mutant on the spike of SARS-CoV-2
Q Zhang, B Ju, J Ge, JFW Chan… - Nature …, 2021 - pubmed.ncbi.nlm.nih.gov
Neutralizing antibodies (nAbs) to SARS-CoV-2 hold powerful potentials for clinical
interventions against COVID-19 disease. However, their common genetic and biologic …
interventions against COVID-19 disease. However, their common genetic and biologic …